Results 221 to 230 of about 7,546 (298)

Interleukin‐2 Deprived State of Regulatory T cells and Their Recovery by Low‐Dose Interleukin‐2 in Patients With Inflammatory Myopathies

open access: yesArthritis &Rheumatology, Volume 78, Issue 11, Page 2341-2350, November 2026.
Objective Regeneration and expansion of Treg by low‐dose interleukin‐2 (IL‐2) therapy is considered a potential treatment strategy for a wide range of autoimmune diseases. To provide a pathophysiologically‐based rationale for low‐dose IL‐2 therapy, we investigated whether reversible defects in the Treg–IL‐2 axis emerge in inflammatory myopathies ...
Justus Ohmes   +10 more
wiley   +1 more source

The meningeal-cerebellar axis: a new perspective on cerebellar development. [PDF]

open access: yesCell Mol Life Sci
Al-Sayyar A   +6 more
europepmc   +1 more source

Beyond Greenwashing: Impact of Circular Economy Practices on Green Collaborative Practices and Sustainable Supply Chain Integration Through Green Value Co‐Creation

open access: yesBusiness Strategy and the Environment, Volume 35, Issue 7, Page 9569-9583, November 2026.
ABSTRACT This study examines the influence of circular economy practices, as a manifestation of corporate social responsibility, on green value co‐creation and its subsequent effects on green collaborative practices and sustainable supply chain integration between providers and customers.
Adriana Santos   +2 more
wiley   +1 more source

Shortened Obinutuzumab Infusion Is Safe and Reduces Chair Time in Frontline Treatment of Chronic Lymphocytic Leukemia: A Real‐World Study

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
In treatment‐naïve CLL, a shortened obinutuzumab infusion was as safe as standard infusion, did not increase infusion‐related reactions, and significantly reduced chair time, improving outpatient unit efficiency. ABSTRACT Background Obinutuzumab‐based regimens are established frontline treatments for chronic lymphocytic leukemia (CLL), but infusion ...
Dominika Écsiová   +6 more
wiley   +1 more source

Onset of Action of Azelastine 0.15% Versus Olopatadine/Mometasone for Allergen‐Induced Rhinitis: An EEU Crossover Study

open access: yesClinical and Translational Allergy, Volume 16, Issue 11, November 2026.
ABSTRACT Background The aim of this study was to compare the onset of action (primary), and overall efficacy (secondary) of azelastine nasal spray 0.15% (AZE 0.15%) with mometasone/olopatadine combination therapy (OloMom) in subjects with allergen‐induced rhinitis under controlled allergen exposure conditions in an Environmental Exposure Unit (EEU ...
Jean Bousquet   +5 more
wiley   +1 more source

Artificial Intelligence‐Based Urine Volatomic Assay for Multi‐Cancer Detection: A Multicentric Case–Control Discovery and Internal Validation Study

open access: yesCancer Reports, Volume 9, Issue 11, November 2026.
ABSTRACT Background Multi‐cancer detection assays may extend early‐detection efforts beyond organ‐specific screening programs and support emerging models of oncologic primary care, including age‐ and risk‐stratified multi‐cancer screening. We evaluated urine volatile organic compound profiles (volatome), an emerging biomarker source, for its ...
Scott Campit   +3 more
wiley   +1 more source

Taxon‐Specific Loss in Scleractinian Living Coral Area Following a Bleaching Event Is Linked to Reef Structural Decline in the Central Red Sea

open access: yesEcology and Evolution, Volume 16, Issue 11, November 2026.
Coral bleaching is becoming more frequent and severe worldwide, yet its effects on reef structural complexity remain poorly understood compared with the well‐documented impacts on coral colonies and communities. We used a cross‐scale approach to link in situ thermal stress to coral colony‐scale bleaching and mortality and reef‐scale structural change ...
Natalie Dunn   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy